US2011183341A1PendingUtilityA1
Use of 14-3-3-Proteins in Treatment and Prevention of Neurodegeneration
Est. expiryNov 7, 2027(~1.2 yrs left)· nominal 20-yr term from priority
G01N 33/6896G01N 2800/2835
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure is directed to methods for treatment and prevention of disease states characterized by a decreased 14-3-3 polypeptide expression or activity. In one embodiment, the present disclosure provides methods for the treatment and/or prevention of Parkinson's disease, neurodegeneration and/or diseases characterized, at least in part, by neurodegeneration, by increasing a 14-3-3 polypeptide activity.
Claims
exact text as granted — not AI-modified1 . A method of diagnosing a subject as suffering from or at risk for Parkinson's disease.
Join the waitlist — get patent alerts
Track US2011183341A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.